Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dynein axonemal heavy chain 5 is a large, ATPase-containing motor protein encoded by the DNAH5 gene in humans[1][2][5]. It is a key component of the outer dynein arms in motile cilia, generating the force required for ciliary beating by converting chemical energy from ATP hydrolysis into mechanical work[3][5]. This activity is critical for normal respiratory function, reproductive health, and correct placement of internal organs during embryonic development[1][2]. Dysfunction or mutations in DNAH5 are causative for primary ciliary dyskinesia, which manifests as recurrent respiratory infections, abnormal organ laterality (situs inversus or heterotaxy), and reduced fertility[1][2][5]. The protein’s biochemical mechanism involves cyclic ATP-driven conformational changes that move microtubules within the axoneme, producing wave-like ciliary movement[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dynein axonemal heavy chain 5 (DNAH5).